Company / SG&A Expense
Privia Health Group, Inc. SG&A Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$138.2M
FY2025
5-year range
$109.6M / $255.9M
FY2021-FY2025
Trend
+9.5%
vs FY2024
Sector context
#125 of 158
Health Care
What the data says
Privia Health Group, Inc.'s sg&a expense of $138M is lower than 79% of companies in the Health Care sector (FY2025). Increased from $110M to $138M over the past 2 years.
Based on SEC 10-K filings.
$138M in FY2025 with a 5-year CAGR of +25.7%.
Increased from $110M to $138M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +2.2%
- 5-Year CAGR
- +25.7%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 158This company $138.2M Sector average $175.9B
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +25.7%, indicating consistent growth.
- In FY2025, sg&a expense increased 9.5% year-over-year.
- Ranks #125 out of 158 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $138.2M | +9.5% |
| FY2024 | $126.2M | +15.1% |
| FY2023 | $109.6M | -15.4% |
| FY2022 | $129.6M | -49.4% |
| FY2021 | $255.9M | +481.3% |
| FY2020 | $44.0M | +5.2% |
| FY2019 | $41.8M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026